α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis

G. Leandro, Daniela Basso, C. Fabris, S. Zizzari, Silvana Elba, G. Del Favero, F. Di Mario, Tamara Meggiato, Cristina Angonese, R. Naccarato

Research output: Contribution to journalArticle

Abstract

This study was undertaken in order to compare the usefulness of three indices of tumour proliferation in detecting primary hepatocellular carcinoma (HCC) and in differentiating this neoplasm from liver cirrhosis. In 10 patients with HCC and in 63 with liver cirrhosis serum α-fetoprotein (AFP), tissue polypeptide antigen (TPA) and ferritin were assayed. Increased levels of AFP but not of TPA and ferritin were observed in HCC as compared to liver cirrhosis. The receiver-operating characteristic curves demonstrated that AFP is more discriminating between HCC and liver cirrhosis than the other two markers. Correlations between liver function tests and serum markers were observed in liver cirrhosis but not in HCC. We can conclude that AFP is more useful than TPA and ferritin in detecting HCC in patients with liver cirrhosis, owing to the high frequency of false positive results of the latter two indices in liver cirrhosis. Liver dysfunction is probably involved in increasing all these markers of malignancy, thus reducing the specificity of these tests.

Original languageEnglish
Pages (from-to)276-278
Number of pages3
JournalJournal of Cancer Research and Clinical Oncology
Volume115
Issue number3
DOIs
Publication statusPublished - Jun 1989

Fingerprint

Tissue Polypeptide Antigen
Fetal Proteins
Ferritins
Liver Cirrhosis
Hepatocellular Carcinoma
Neoplasms
Liver Function Tests
ROC Curve
Liver Diseases
Biomarkers

Keywords

  • Liver cirrhosis
  • Liver dysfunction
  • Primary hepatocellular carcinoma
  • Tumour markers

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis. / Leandro, G.; Basso, Daniela; Fabris, C.; Zizzari, S.; Elba, Silvana; Del Favero, G.; Di Mario, F.; Meggiato, Tamara; Angonese, Cristina; Naccarato, R.

In: Journal of Cancer Research and Clinical Oncology, Vol. 115, No. 3, 06.1989, p. 276-278.

Research output: Contribution to journalArticle

Leandro, G, Basso, D, Fabris, C, Zizzari, S, Elba, S, Del Favero, G, Di Mario, F, Meggiato, T, Angonese, C & Naccarato, R 1989, 'α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis', Journal of Cancer Research and Clinical Oncology, vol. 115, no. 3, pp. 276-278. https://doi.org/10.1007/BF00391702
Leandro, G. ; Basso, Daniela ; Fabris, C. ; Zizzari, S. ; Elba, Silvana ; Del Favero, G. ; Di Mario, F. ; Meggiato, Tamara ; Angonese, Cristina ; Naccarato, R. / α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis. In: Journal of Cancer Research and Clinical Oncology. 1989 ; Vol. 115, No. 3. pp. 276-278.
@article{b35e755340754e4eb19b878cd116426f,
title = "α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis",
abstract = "This study was undertaken in order to compare the usefulness of three indices of tumour proliferation in detecting primary hepatocellular carcinoma (HCC) and in differentiating this neoplasm from liver cirrhosis. In 10 patients with HCC and in 63 with liver cirrhosis serum α-fetoprotein (AFP), tissue polypeptide antigen (TPA) and ferritin were assayed. Increased levels of AFP but not of TPA and ferritin were observed in HCC as compared to liver cirrhosis. The receiver-operating characteristic curves demonstrated that AFP is more discriminating between HCC and liver cirrhosis than the other two markers. Correlations between liver function tests and serum markers were observed in liver cirrhosis but not in HCC. We can conclude that AFP is more useful than TPA and ferritin in detecting HCC in patients with liver cirrhosis, owing to the high frequency of false positive results of the latter two indices in liver cirrhosis. Liver dysfunction is probably involved in increasing all these markers of malignancy, thus reducing the specificity of these tests.",
keywords = "Liver cirrhosis, Liver dysfunction, Primary hepatocellular carcinoma, Tumour markers",
author = "G. Leandro and Daniela Basso and C. Fabris and S. Zizzari and Silvana Elba and {Del Favero}, G. and {Di Mario}, F. and Tamara Meggiato and Cristina Angonese and R. Naccarato",
year = "1989",
month = "6",
doi = "10.1007/BF00391702",
language = "English",
volume = "115",
pages = "276--278",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - α-Fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis

AU - Leandro, G.

AU - Basso, Daniela

AU - Fabris, C.

AU - Zizzari, S.

AU - Elba, Silvana

AU - Del Favero, G.

AU - Di Mario, F.

AU - Meggiato, Tamara

AU - Angonese, Cristina

AU - Naccarato, R.

PY - 1989/6

Y1 - 1989/6

N2 - This study was undertaken in order to compare the usefulness of three indices of tumour proliferation in detecting primary hepatocellular carcinoma (HCC) and in differentiating this neoplasm from liver cirrhosis. In 10 patients with HCC and in 63 with liver cirrhosis serum α-fetoprotein (AFP), tissue polypeptide antigen (TPA) and ferritin were assayed. Increased levels of AFP but not of TPA and ferritin were observed in HCC as compared to liver cirrhosis. The receiver-operating characteristic curves demonstrated that AFP is more discriminating between HCC and liver cirrhosis than the other two markers. Correlations between liver function tests and serum markers were observed in liver cirrhosis but not in HCC. We can conclude that AFP is more useful than TPA and ferritin in detecting HCC in patients with liver cirrhosis, owing to the high frequency of false positive results of the latter two indices in liver cirrhosis. Liver dysfunction is probably involved in increasing all these markers of malignancy, thus reducing the specificity of these tests.

AB - This study was undertaken in order to compare the usefulness of three indices of tumour proliferation in detecting primary hepatocellular carcinoma (HCC) and in differentiating this neoplasm from liver cirrhosis. In 10 patients with HCC and in 63 with liver cirrhosis serum α-fetoprotein (AFP), tissue polypeptide antigen (TPA) and ferritin were assayed. Increased levels of AFP but not of TPA and ferritin were observed in HCC as compared to liver cirrhosis. The receiver-operating characteristic curves demonstrated that AFP is more discriminating between HCC and liver cirrhosis than the other two markers. Correlations between liver function tests and serum markers were observed in liver cirrhosis but not in HCC. We can conclude that AFP is more useful than TPA and ferritin in detecting HCC in patients with liver cirrhosis, owing to the high frequency of false positive results of the latter two indices in liver cirrhosis. Liver dysfunction is probably involved in increasing all these markers of malignancy, thus reducing the specificity of these tests.

KW - Liver cirrhosis

KW - Liver dysfunction

KW - Primary hepatocellular carcinoma

KW - Tumour markers

UR - http://www.scopus.com/inward/record.url?scp=0024402270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024402270&partnerID=8YFLogxK

U2 - 10.1007/BF00391702

DO - 10.1007/BF00391702

M3 - Article

C2 - 2473990

AN - SCOPUS:0024402270

VL - 115

SP - 276

EP - 278

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 3

ER -